Frontier Pharma Report 2016: Diabetic Complications -

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Frontier Pharma Report 2016: Diabetic Complications - Regulatory and Reimbursement Policy Shifts Favor First-in-Class Product Innovation

Dublin, July 28, 2016 (GLOBE NEWSWIRE) -- Research and Markets has announced the addition of the "Frontier Pharma: Diabetic Complications - Innovative and Diverse Neuropathies, Nephropathy and Retinopathies Pipelines Demonstrate Shift Towards Disease Modifying Therapies" report to their offering. Diabetes is a common long-term condition that can lead to a range of disparate and serious complications. It is a lifelong, multi-systemic condition that affects a number of integral organs. Diabetes has a rapidly increasing prevalence - it currently affects 10% of adults globally, and is estimated to become the seventh-leading cause of death by 2030. The lack of absolute treatment for the condition and the difficulty in maintaining constant glycemic control, even following adequate treatment, can result in a range of complications. The three main indication groups are diabetic nephropathy, which is a progressive condition caused by damage to the capillaries and kidneys glomeruli as a result of diabetes; diabetic retinopathy, which is defined as damage to the retina as a result of high blood sugar; and a range of diabetic neuropathies, a group of conditions in which nerve damage is caused as a result of diabetes mellitus. The need for improved therapeutics within diabetic complications is especially prominent in comparison with other multi-systemic conditions, as the market is currently predominantly composed of therapies that symptomatically treat the condition, or at best slow disease progression. However, as the understanding of disease pathophysiology in both diabetes and its complications increases, new targets are being identified and converted into improved therapeutic options that are better aligned with the underlying disease pathophysiology than their predecessors. The diabetic complications pipeline consists of 429 products that contain an array of targets not currently in use within the market. The increase in molecular target diversity signifies the high potential for changes and improvements in the diabetic complications market. One innovative therapy is CBX-129801, a promising synthetic peptide that is currently in development for diabetic neuropathy. Innovation can also be seen within diabetic retinopathy, with therapies such as BCN070660, a topical ophthalmologic formulation currently in development. Key Topics Covered: 1 Tables & Figures 2 Executive Summary 2.1 Significant Unmet Needs in Diabetic Complications Market 2.2 High Proportion of First-in-Class Innovation Offers Promise in Diabetic Complications 2.3 Deal Activity Varies with First-in-Class Status 3 The Case for Innovation 3.1 Growing Opportunities for Biologic Products 3.2 Diversification of Molecular Targets 3.3 Innovative First-in-Class Product Development Remains Attractive 3.4 Regulatory and Reimbursement Policy Shifts Favor First-in-Class Product Innovation 3.5 Sustained Innovation 3.6 Research Report Guidance 4 Clinical and Commercial Landscape 4.1 Diabetes Mellitus Overview 4.2 Diabetic Neuropathies 4.3 Diabetic Nephropathy 4.4 Diabetic Retinopathies 4.5 Overview of Marketed Products in Diabetic Complications 5 Assessment of Pipeline Product Innovation 5.1 Diabetic Neuropathies by Molecule Type, Phase and Therapeutic Target 5.2 Diabetic Nephropathy by Molecule Type, Phase and Therapeutic Target 5.3 Diabetic Retinopathies by Molecule Type, Phase and Therapeutic Target 6 Signaling Network, Disease Causation and Innovation Alignment 6.1 Complexity of Signaling Networks in Metabolic Disorders 6.2 First-in-Class Matrix Assessment 7 First-in-Class Target Evaluation 7.1 Pipeline Programs Targeting NADPH Oxidase 4 7.2 Pipeline Programs Targeting Glutamate Decarboxylase 7.3 Pipeline Programs Targeting Growth Hormone Secretagogue Receptor Type 1 7.4 Pipeline Programs Targeting Motilin Receptor 7.5 Pipeline Programs Targeting Lysophosphatidic Acid Receptor 1 7.6 Pipeline Programs Targeting Leukotriene B4 Receptor 1 7.7 Pipeline Programs Targeting Integrin Alpha V 7.8 Pipeline Programs Targeting Signal Transducer and Activator of Transcription 4 8 Deals and Strategic Consolidations 8.1 Industry-Wide First-in-Class Deals 8.2 Licensing Deals 8.3 Co-development Deals 8.4 First-in-Class Programs Not Involved in Licensing or Co-development Deals 9 Appendix For more information visit http://www.researchandmarkets.com/research/x2...ier_pharma

CONTACT: Research and Markets Laura Wood, Senior Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900 U.S. Fax: 646-607-1907 Fax (outside U.S.): +353-1-481-1716 Sector: Pharmaceuticals, Liver and Kidney Disorders Drugs , Endocrine and Metabolic Disorder Drugs

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Championing Change: USTA Mid-Atlantic Gala's Impact

Updated Category News Views 309

A Night to Remember: USTA Mid-Atlantic's Gala Who would've thought tennis could wield such transformative power? This ain't your average sport gala. Last Saturday, a crowd of over 300 gathered at the Ritz-Carlton Tysons Corner for the USTA Mid-Atlantic Foundation's 2026 Tennis Creates Gala. Hosted by the formidable Malika Andrews, this event wasn't just a fancy...

Continue Reading
Portillo's Faces Class Action: Investor Losses at Stake

Updated Category News Views 234

Investor Tensions Rise as Portillo's Inc. Lawsuit Unfolds Investment ain't all sunshine and rainbows, and if you've been holding Portillo's Inc. (NASDAQ: PTLO) stocks between September 19, 2023, and May 4, 2026, you might find yourself caught in a storm front. We're talking shareholder class action lawsuit, folks, thanks to some allegedly misguided management moves. This...

Continue Reading
InstaHeat 35K: FOGATTI Offers Upgraded RV Furnace Control

Updated Category News Views 459

Winter RV Trips Just Got Cozier There's nothing quite like hitting the open road in an RV during the winter months. But let's face it, nobody wants to return to a cabin that's as frigid as the great outdoors. Here's where FOGATTI steps up its game with the InstaHeat Ultra 35K RV Furnace. They’ve tinkered with the thermostat to iron out more precise control, just in time...

Continue Reading
Kayla Harrison Dominates UFC 334, Earns Big Win

Updated Category News Views 59

Kicking off UFC 334 with a bang, Kayla Harrison didn't just step into the Octagon—she bulldozed her way through Amanda Nunes to retain her Women's Bantamweight Championship. This showdown didn't just electrify New York's Madison Square Garden, it shook the entire MMA landscape. Harrison, the face of Monster Energy's athlete roster, wasn't content with just defending her...

Continue Reading
KINGRVER Boosts RV Comfort with New Water Heater Lineup

Updated Category News Views 328

An Upgrade for the Open Road In the land of RV living, comfort is king—or in this case, KINGRVER. Dropping affordable upgrades for water heaters into the world of RVs, KINGRVER's CT6 lineup is like a warm hug on a chilly campsite morning. Whether you've pulled up to a wooded retreat or parked under the vast desert sky, having dependable hot water shouldn't be a gamble....

Continue Reading
Investors Gear Up for Lennar Class Action Lawsuit

Updated Category News Views 322

High Stakes and Hard Hits for Lennar Stockholders There’s rarely a dull moment in the world of Wall Street, and Lennar Corporation (NYSE: LEN) is proving that rule right now. As a whiff of scandal wafts through the air, the famed homebuilder and its bigwigs are staring down the barrel of a formidable class action lawsuit. The question is, just how deep do the alleged...

Continue Reading
LONGi's Four Paths to Global Green Development

Updated Category News Views 0

LONGi's Vision: A Cleaner, Greener Future Amidst the buzz at COP31 in Antalya, LONGi is making waves with promises of a cleaner future. They're not just throwing around eco-friendly slogans—this company's laying down real pathways to tackle climate change, one solar panel at a time. Aiming for Industrial Transformation LONGi's got their sights set on shaking up...

Continue Reading
Novo's CagriSema Trials Show Promising Weight Loss

Updated Category News Views 393

Decoding CagriSema's Promise Let me tell you, when those corporate folks from Novo Nordisk announce something big like their investigational drug CagriSema at ObesityWeek® 2026, it’s time to take notice. This isn’t just your average press release about some new weight loss fad. We’re talking about a phase 3 REDEFINE 1 trial that opens up a treasure chest of data...

Continue Reading
Beef 'O' Brady's Expands Into Tuscaloosa Market

Updated Category News Views 290

A New Player in Town: Beef 'O' Brady's Lands in Tuscaloosa Listen up, sports fans and pub grub lovers of Tuscaloosa! Beef 'O' Brady's just kicked down the doors and expanded its reach, opening a location smack on McFarland Boulevard. The place threw open its doors on October 26 and is set to make waves in the local scene, driven by the dedicated hands of Mitul Patel and...

Continue Reading
Princess Cruises Launches New Era at Celebration Key

Updated Category News Views 185

Never thought I'd see the day when a cruise ship docking would stir such excitement, but here we are. The Star Princess has made its grand debut at Celebration Key, the latest jewel in Princess Cruises' crown. And they're going all out with Bahamian flair—something about a Junkanoo band and beach art that would make even the crustiest sailor crack a smile. Inaugural Fun...

Continue Reading

Top 5 Most Recently Viewed Articles

La Française des Jeux Implements Squeeze-Out Rights on Kindred Group

Updated Category News Views 69

La Française des Jeux Implements Squeeze-Out Rights on Kindred Group Kindred Group plc, one of the major players in the online gambling sector, finds itself in the spotlight following a recent notice from La Française des Jeux (FDJ). The notification signifies an important step, reflecting the dynamic nature of the industry's landscape. Understanding the Squeeze-Out...

Continue Reading
Inspirato Set to Reveal Q3 2024 Financial Results Soon

Updated Category News Views 85

Upcoming Q3 2024 Results Announcement Inspirato Incorporated (NASDAQ: ISPO), recognized as a premier luxury vacation club, has scheduled its release of financial and operating results for the third quarter of 2024. This announcement is anticipated to take place after market closure on Monday. As an entity that redefines luxury travel experiences, this news is particularly...

Continue Reading
Empowering the Future: Leadership Course at Milton Hershey School

Updated Category News Views 202

Leadership Development for Milton Hershey School Students Milton Hershey School (MHS) offers its high school students a remarkable opportunity to engage in a college-level summer course focused on leadership. This initiative is particularly designed for students advancing into their junior and senior years, allowing them to enrich their academic profile while developing...

Continue Reading
Viavi Solutions Shows Promising Growth Amid Market Pressures

Updated Category News Views 330

Viavi Solutions Adjusts Forecasts Following Financial Insights Recently, an analyst from Rosenblatt made notable adjustments to the financial outlook for Viavi Solutions (NASDAQ: VIAV), raising the price target from $8.25 to $10.50. The update came after reviewing the firm’s earnings report for the first quarter of fiscal year 2025, which revealed that revenue and...

Continue Reading
180 Degree Capital Corp. Evaluates Proposal from Source Capital

Updated Category News Views 197

180 Degree Capital Corp. Evaluates Source Capital Proposal 180 Degree Capital Corp. (NASDAQ: TURN) is committed to ensuring that its shareholders are informed and adequately represented when it comes to corporate developments. Recently, the company’s Board of Directors took a significant step by analyzing a non-binding proposal put forth by Source Capital. The proposal,...

Continue Reading